Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Pfizer
|
| gptkbp:acquisitionYear |
2010
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:defunct |
2010
|
| gptkbp:foundedIn |
1993
|
| gptkbp:founder |
gptkb:John_Gregory
|
| gptkbp:headquartersLocation |
gptkb:Bristol,_Tennessee,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
King Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Altace
gptkb:Levoxyl gptkb:Skelaxin |
| gptkbp:numberOfEmployees |
over 2,600 (at peak)
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
KG
|
| gptkbp:tradedOn |
gptkb:NYSE
|
| gptkbp:bfsParent |
gptkb:Pfizer
|
| gptkbp:bfsLayer |
4
|